Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database - CRLC Val d'Aurelle - Paul Lamarque Accéder directement au contenu
Article Dans Une Revue Neuro-Oncology Année : 2017

Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database

1 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
2 UT - Université de Tours
3 INM - Institut des Neurosciences de Montpellier
4 SLA CHRU Montpellier - Centre référent Sclérose Latérale Amyotrophique [CHRU Montpellier]
5 UPD5 Médecine - Université Paris Descartes - Faculté de Médecine
6 ICM - UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle
7 PRC - Physiologie de la reproduction et des comportements [Nouzilly]
8 CIC - Centre d’Investigation Clinique [Tours] CIC 1415
9 IBV - Institut de Biologie Valrose
10 Service de Pathologie [CHU de Dijon]
11 Service de neurochirurgie [CHU Nantes]
12 CHU Pitié-Salpêtrière [AP-HP]
13 Hôpital JeanMinjoz
14 Service de neurochirurgie [Brest]
15 CIC Brest
16 Service de Neurochirurgie [CHU Rouen]
17 Service d'anatomie pathologique et histologie-cytologie [Rangueil]
18 Sérine protéases et physiopathologie de l'unité neurovasculaire
19 Service de neurochirurgie [CHU Dijon]
20 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
21 Laboratoire de Neuropathologie
22 CHU Clermont-Ferrand
23 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
24 Service Neurochirurgie A et B [CHU Clermont-Ferrand]
25 COSS - Chemistry, Oncogenesis, Stress and Signaling
26 CHU de Bordeaux - Centre Hospitalier Universitaire de Bordeaux
27 Service de neurochirurgie
28 Hôpital Pellegrin
29 Fondation Ophtalmologique Adolphe de Rothschild [Paris]
30 Service Neurochirurgie [CHU Toulouse]
31 LKB (Lhomond) - Laboratoire Kastler Brossel
32 Service de neurochirurgie [CHU Angers]
33 Service de neurochirurgie [CHU Marseille]
34 CIMoTHeMA [Poitiers] - Cibles moléculaires et thérapeutiques de la maladie d'Alzheimer [EA 3808]
35 HLSO - Hôpital La Source [Orléans]
36 Hôpital Nord [CHU - APHM]
37 CRCINA-ÉQUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma
38 Service Anatomie et cytologie pathologiques [CHU Toulouse]
39 MAC - Laboratoire Mouvement Adaptation Cognition
40 Cellules souches leucémiques et thérapeuthiques
41 UPD5 - Université Paris Descartes - Paris 5
42 USPC - Université Sorbonne Paris Cité
43 iBraiN - Imaging, Brain & Neuropsychiatry
44 ACPNP - Service d'Anatomo-Cyto-Pathologie et de NeuroPathologie [Hôpital de la Timone - APHM]
Luc Bauchet
Philippe Cornu
  • Fonction : Auteur
  • PersonId : 856089
Alain Czorny
  • Fonction : Auteur
Vincent Lubrano
  • Fonction : Auteur
  • PersonId : 935779
  • IdRef : 108136728
Emmanuel Mandonnet
Philippe Menei
  • Fonction : Auteur
  • PersonId : 910996
  • IdRef : 076585468
Philippe Metellus
  • Fonction : Auteur
  • PersonId : 1002610
Jimmy Voirin
  • Fonction : Auteur
Stéphane Velut

Résumé

Background - Anaplastic gangliogliomas (GGGs) are rare tumors whose natural history is poorly documented. We aimed to define their clinical and imaging features and to identify prognostic factors. Methods - Consecutive cases of anaplastic GGGs in adults prospectively entered into the French Brain Tumor Database between March 2004 and April 2014 were screened. After diagnosis was confirmed by pathological review, clinical, imaging, therapeutic, and outcome data were collected retrospectively. Results - Forty-three patients with anaplastic GGG (median age, 49.4 y) from 18 centers were included. Presenting symptoms were neurological deficit (37.2%), epileptic seizure (37.2%), or increased intracranial pressure (25.6%). Typical imaging findings were unifocal location (94.7%), contrast enhancement (88.1%), central necrosis (43.2%), and mass effect (47.6%). Therapeutic strategy included surgical resection (95.3%), adjuvant radiochemotherapy (48.8%), or radiotherapy alone (27.9%). Median progression-free survival (PFS) and overall survival (OS) were 8.0 and 24.7 months, respectively. Three- and 5-year tumor recurrence rates were 69% and 100%, respectively. The 5-year survival rate was 24.9%. Considering unadjusted significant prognostic factors, tumor midline crossing and frontal location were associated with shorter OS. Temporal and parietal locations were associated with longer and shorter PFS, respectively. None of these factors remained statistically significant in multivariate analysis. Conclusions - We report a large series providing clinical, imaging, therapeutic, and prognostic features of adult patients treated for an intracerebral anaplastic GGG. Our results show that pathological diagnosis is difficult, that survivals are only slightly better than for glioblastomas, and that complete surgical resection followed with adjuvant chemoradiotherapy offers longer survival.
Fichier principal
Vignette du fichier
now186.pdf (1.15 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02051153 , version 1 (03-07-2024)

Identifiants

Citer

Louis-Marie Terrier, Luc Bauchet, Valérie Rigau, Aymeric Amelot, Sonia Zouaoui, et al.. Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database. Neuro-Oncology, 2017, 19 (5), pp.678-688. ⟨10.1093/neuonc/now186⟩. ⟨hal-02051153⟩
496 Consultations
7 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More